Submitted by Anonymous (not verified) on 5 August 2025 - 15:12
Human medicines European public assessment report (EPAR): Rixathon, rituximab, Date of authorisation: 15/06/2017, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rixathon, rituximab, Date of authorisation: 15/06/2017, Revision: 15, Status: Authorised